Frontiers

Frontiers is an award-winning Open Science platform and leading Open Access scholarly publisher. Our mission is to make research results openly available to the world, thereby accelerating scientific and technological innovation, societal progress and economic growth. Covering more than 600 academic disciplines, our 100+ journals are led and peer-reviewed by editorial boards of over 100,000 top researchers.

Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. Frontiers in Immunology is an open-access journal at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. The journal is led by Field Chief Editor Dr. Luigi Daniele Notarangelo, who is supported by an outstanding Editorial Board of international researchers. For more information, visit https://www.frontiersin.org/journals/immunology and follow @FrontImmunol on Twitter.

Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS).

Journal Manager attending this meeting

Alessandra Fornarelli, Frontiers in Immunology

Alessandra Fornarelli graduated from the University of Piemonte Orientale in Novara, Italy, and completed a doctoral degree at the University of Bonn, Germany, working at the German Center for Neurodegenerative diseases (DZNE) in the laboratory led by Professor Pierluigi Nicotera. She joined Frontiers in 2016, working on several journals before becoming journal manager for Frontiers in Immunology in January 2018.

Email Alessandra should you have any questions: alessandra.fornarelli@frontiersin.org

Frontiers highlighted Research Topics

COVID-19: Pathophysiology, epidemiology, clinical management and public health response
389 articles | Led by Dr. Denise Doolan & 16 other leading researchers

Interdisciplinary research addressing knowledge gaps and generating evidence for the improved management and control of COVID-19, with scientific contributions from all areas of virology, immunology, clinical microbiology, epidemiology, therapeutics, communications as well as infection prevention and public health risk assessment and management studies.

Development of Vaccines Against Emerging Pathogens

14 articles | Led by Dr. Katie Ewer, Dr. Teresa Lambe and Dr. Neeltje van Doremalen

ARDS in COVID-19 - Insights for Treatment

Open for submission | Led by Drs. Yoshiro Maru, Koichi Ikuta, Michael Karin, Yoshio Koyanagi and Kensuke Miyake

Frontiers highlighted articles

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) | Original Research article

Interferon-α2b Treatment for COVID-19 | Original Research article

T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis | Original Research article

Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines | Original Research article

The COVID-19 Cytokine Storm; What We Know So Far | Review

Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control | Review

Immune Response, Inflammation, and the Clinical Spectrum of COVID-19 | Review

Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper | Hypothesis and Theory

Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection | Perspective

» See all COVID-19-related Research Topics
» See all COVID-19-related articles
» Coronavirus Knowledge Hub: the latest science & resources

Why launch a Frontiers Research Topic?

Frontiers’ Research Topicsare peer-reviewed article collections around cutting-edge research themes. Defined, managed and led by renowned researchers, they unite the world’s leading experts around the hottest topics, stimulating collaboration and accelerating science. Managed and disseminated on Frontiers’ Open Science platform, these collections are free to access and highly visible, increasing readership and citations for your research.

Frontiers highlights

• Gold open-access publisher
• 5th most-cited of world's 20 largest publishers
• Rigorous, constructive, efficient and transparent peer review
• Average time from submission to final decision: 90 days